Le Lézard
Classified in: Health, Science and technology
Subject: Photo/Multimedia

Statement from Biocom California and MassBio on America's Biotechnology Leadership and National Security


The following statement can be attributed to Joe Panetta, Biocom California's president and CEO, and Kendalle Burlin O'Connell, Massachusetts Biotechnology Council's (MassBio) CEO and president.

"We strongly support efforts to continue American leadership in the biotechnology sector. We must look at ways to expand domestic capabilities for pharmaceutical research and manufacturing to ensure patient access to innovative medicines often developed by smaller companies that are most reliant on federal grants or contracts. We know that a strong American biotechnology sector is a key national security asset and will continue to work with policymakers and industry leaders to accomplish our shared goals of promoting access to innovation for American patients while protecting our national security."

About Biocom California

Biocom California is the leader and advocate for California's life science sector. We work on behalf of more than 1,700 members to drive public policy, build an enviable network of industry leaders, create access to capital, introduce cutting-edge STEM education programs and create robust value-driven purchasing programs.

Founded in 1995 in San Diego, Biocom California provides the strongest public voice to research institutions and companies that fuel the local and state-wide economy. Our goal is simple: to help our members produce novel solutions that improve the human condition. In addition to our San Diego headquarters, Biocom California operates core offices in Los Angeles and the San Francisco Bay Area, with satellite offices in Sacramento, Washington, D.C. and Tokyo. Our broad membership benefits apply to biotechnology, pharmaceutical, medical device, genomics and diagnostics companies of all sizes, as well as to research universities and institutes, clinical research organizations, investors and service providers.

For more information on Biocom California, please visit our website at www.biocom.org. Connect with us on LinkedIn, Facebook, and X.

About MassBio

MassBio's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. MassBio represents the premier global life sciences and healthcare hub, with 1,600+ members dedicated to preventing, treating, and curing diseases through transformative science and technology that brings value and hope to patients. Founded in 1985, MassBio works to advance policy and promote education, while providing member programs, events, industry thought leadership, and services for the #1 life sciences cluster in the world.

For more information on MassBio, please visit our website at www.massbio.org. Connect with us on LinkedIn, X, Instagram, and MB Vision, our online video library.


These press releases may also interest you

at 21:09
In the news release, The Deadly Cost of Artificial Stone: Fabrication Workers Face Accelerated Silicosis Epidemic as Industry Scrambles for Safer Alternatives, issued 11-Feb-2025 by Brayton Purcell LLP over PR Newswire, we are advised by the company...

at 20:33
Report with market evolution powered by AI - The global pharmaceuticals wholesale and distribution market  size is estimated to grow by USD 896.5 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  9.45% ...

at 20:22
Report on how AI is redefining market landscape - The global health and wellness food market size is estimated to grow by USD 627.6 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of 9.8% during the forecast...

at 20:17
Report with market evolution powered by AI - The fundus camera market and it is set to grow by USD 174.65 thousand from 2025 to 2029. However, the growth momentum will progressing at a CAGR of over 6.2% during the forecast period, according to...

at 20:00
On 12 Feb 2025 (Singapore Time), Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an international multicenter Phase...

at 19:50
Oqory, Inc., a private biopharmaceutical company dedicated to developing next-generation antibody drug conjugates (ADCs) for the treatment of cancer, today announced that Michael King, Chief Executive Officer, will present data at Oppenheimer's 35th...



News published on and distributed by: